A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol
FI: 1,883
Type: Letter
Collaboration
Year: 2020
Writers
Rodriguez-Rubio, M; Figueira, JC; Acuna-Castroviejo, D; Borobia, AM; Scales, G; de la Oliva, P.
Magazine
Title: TRIALS
Quartile
- Q3